UBE Corporation (UBEOF) Fair Value & Analysis
Basic Materials · US · Market cap $1.5B
Analysis
UBE Corporation (UBEOF) currently trades at $15.29, while our model-based Fair Value estimate is $21.82 — implying the stock looks roughly 42.8% undervalued today. We read business quality at 94/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
UBE Corporation, together with its subsidiaries, engages in the materials and machinery businesses in Japan, Asia, Europe, North America, and internationally. The company operates through Functional Products, High-Performance Urethanes, Pharmaceuticals, Resin and Chemical Products, Machinery, and Others segments. Its Functional Products segment offers polyimides, separation membranes, ceramics, and separators. The High-Performance Urethanes segment provides urethane resin intermediate, elastomers, and coating products. Its Pharmaceuticals segments engages in the drug discovery and the contract manufacturing and sales of pharmaceutical raw materials and intermediates. The Resin and Chemical Products segment provides composite, nylon polymer, caprolactam, ammonium sulfate, industrial chemicals, and elastomer. Its Machinery segment offers die casting machines, extrusion presses, injection molding machines, ceramics machinery, chemical equipment, crushers, transport machines, dust remov…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.